Malaria is a disease caused by parasites that are transmitted to humans through bites of mosquitoes. According to the World Health Organizations, around half of the global population is at risk of malaria. This has led to increased inclination of various healthcare agencies towards addressing this major problem. Global non-profit organizations such as the Melinda Gates Foundation and PATH are focused on developing preventive measures and saving lives of many in the malaria affected regions. Africa accounts for the 90% of malaria cases and thus, it is the primary target of launching the first malaria vaccine developed by GlaxoSmithKline (GSK) plc. Mosquirix, a malaria vaccine developed by GlaxoSmithKline, which received the EU approval in 2015 and is presently being examined in Africa as a pilot study.
The global malaria vaccines market is expected to be valued at US$ 50.6 million in 2024 and is expected to witness a CAGR of 150.0% during the forecast period (2024 – 2027).
Get Sample Report with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-sample/37
For prevention against malaria, Africans use insecticide-treated mosquito nets and indoor-insecticide spraying. According to the WHO, the use of insecticide-treated mosquito nets in Africa increased by 80% during 2010-2015. Various mosquito repellent products such as patches, creams, coils, mats, and liquids are marketed globally. Moreover, non-profit organizations around the world provide cheap and often free treatment facilities to the malarial affected population in Africa. In fact GSK is determined to sell the vaccines at a much lower cost, which would support global malaria eradication programs. The global malaria vaccines market is expected to witness significant growth, owing to numerous malarial vaccines being under research pipeline.
Since, around 90-95% of population in Africa and South East Asia is at risk of malaria, the malaria vaccine are expected to witness significant demand from these aforementioned regions. Moreover, advent of vaccines for adult population, would be a major breakthrough for the global malaria vaccines market. Below are certain alarming statistics that embarks the need for a malaria vaccine:
- Artemisinin resistance has been detected in five countries – Laos, Cambodia, Myanmar, Vietnam, and Thailand
- Resistance to P. falciparum parasite against the most available anti-malarial medicines is being reported
- According to the National Vector Borne Disease Control Program, around 95% of the population in India reside in malaria endemic areas
- There were 216 million malaria cases globally in 2016 (WHO)
- Africa is the most affected region with 90% of malaria cases and deaths worldwide (WHO)
- Pregnant women, children aged five years and below, and tourists from countries with low incidence rate of malaria are identified as the most susceptible target population for malaria
The global malaria vaccines market is expected to experience a huge trajectory growth with the launch of first malarial vaccine in near future.
Get PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/37
Increasing accessibility and government support to contribute towards the malaria vaccines market growth
IN 2015, the World Health Organization founded a Global Technical Strategy for Malaria 2016-2030 (GTS), with certain defined goals. One of those goal was aimed at eliminating malaria in at least 10 countries. Moreover, the government of India founded Drug Distribution Centers (DDCs) and Fever Treatment Depots (FTDs) in the rural areas for providing easy access to anti-malarial drugs. Regular monitoring and surveillance carried under several government programs has helped to reduce malarial cases in India from 2.03 million in 2010 to 1.1 million in 2015. Hence, increasing support from governmental organizations and global initiatives is expected to drive the global malaria vaccines market growth during the forecast period.
Key pharmaceutical companies in the market and non-profit organizations are focused on research and development of malaria vaccines. Around 31 trials are under progress for malaria vaccine development with a few being blood stage projects. Availability of funds and government support programs is expected to support commercialization of product with successful trial results, eventually fueling growth the global malaria vaccines market.
Major Players in Malaria Vaccines Market
GlaxoSmithKline plc, Sanaria Inc, Nobelpharma Co., Ltd., Sumaya Biotech and GenVec, Inc.
Reasons to Purchase this Report
• To gain an in-depth understanding of Malaria Vaccines market globally
• To identify the on-going trends and anticipated growth in the next nine years
• To help industry consultants, Malaria Vaccines market other stakeholders align their market-centric strategies
• To obtain research-based business decisions and add weight to presentations and marketing strategies
• To gain competitive knowledge of leading market players
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/37
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837